Therapy with gemcitabine in pretreated peripheral T-cell lymphoma patients

scientific article

Therapy with gemcitabine in pretreated peripheral T-cell lymphoma patients is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1023/A:1008409601731
P698PubMed publication ID9932168

P50authorFilippo GherlinzoniQ114576252
P2093author name stringP L Zinzani
S A Pileri
S Tura
P Albertini
M Magagnoli
G F Orcioni
M Bendandi
P2860cites workA phase I clinical, plasma, and cellular pharmacology study of gemcitabineQ28334915
Difluorodeoxycytidine (dFdC)--gemcitabine: a phase I studyQ33355905
Activity of Fludarabine Monophosphate in Patients With Advanced Mycosis Fungoides: A Southwest Oncology Group StudyQ67666592
Combined modality treatment of cutaneous T cell lymphoma: results of a 6-year follow-upQ70294889
Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphomaQ73443100
Peripheral T-cell lymphomas. Clinico-pathologic study of 168 cases diagnosed according to the R.E.A.L. ClassificationQ73597530
P433issue12
P921main subjectperipheral T-cell lymphomaQ7168693
P304page(s)1351-1353
P577publication date1998-12-01
P1433published inAnnals of OncologyQ326122
P1476titleTherapy with gemcitabine in pretreated peripheral T-cell lymphoma patients
P478volume9